Other new Curevo backers include OrbiMed, Sanofi Ventures and HBM Healthcare Investments. Existing investors RA Capital Management, Janus Henderson Investors and Adjuvant Capital participated in ...

Joining Medicxi is an international group of investment funds including OrbiMed, HBM Healthcare Investments, and Sanofi Ventures plus existing investors RA Capital Management, Janus Henderson ...

Joining Medicxi is an international group of investment funds including OrbiMed, HBM Healthcare Investments, and Sanofi Ventures plus existing investors RA Capital Management, Janus Henderson ...

Good evening, ladies and gentlemen, and welcome to the Verrica Pharmaceuticals fourth quarter and full year 2024 corporate update conference call. (Operator Instructions) As a reminder, this ...

This round was co-led by Qiming Venture Partners and existing shareholder Lilly Asia Ventures, with existing investors OrbiMed and Gaorong Capital participating on a super pro-rata basis.

The higher interest expense of $5.4 million was due to Verrica initially borrowing funds pursuant to the OrbiMed credit facility in July 2023. Change in fair value of derivative liability was $2.6 ...

MDxHealth SA ADR reported better-than-expected earnings for the fourth quarter of 2024, with an earnings per share (EPS) of -$0.14, surpassing the forecasted -$0.19. The company also reported ...

This funding, supported by institutional investors such as Perceptive Advisors and OrbiMed, is expected to extend the company's financial stability into the first half of 2026. Additionally ...

Revenue increased 28% to $24.7 million compared to $19.4 million for the prior year period. Tissue-based tests accounted for 81% and 76% of total fourth quarter 2024 and 2023 revenue, respectively ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

It was led by venture capital firm ARCH Venture Partners, with other prominent biotech investors participating, including OrbiMed, Fairmount, Fidelity Management, and Sanofi Ventures. Mirador ...